samedan logo
 
 
spacer
home > ebr > spring 2004 > part two microarrays in the real world: image analysis
PUBLICATIONS
European BioPharmaceutical Review

Part Two Microarrays in the Real World: Image Analysis

The first article of this series described how the performance of microarrays is being continuously optimised through incremental improvements in experimental protocols, consumables and hardware (1). Over the same period, the techniques used to extract results from microarray images have changed little and so now represent one of the key bottlenecks in microarray-based experimentation.

Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Nick Haan and Graham Snudden, Co-Founders of BlueGnome Ltd

Dr Nick Haan trained as a Computer Systems Engineer, but soon moved to pursue his stronger interests in Mathematics and Biology through a PhD at the University of Cambridge. After his PhD, Nick continued at the University of Cambridge as a Research Associate working on the development of advanced statistical inference tools for time evolving systems, much of which has application to the analysis of biotechnology data. Nick co-founded BlueGnome Ltd in late 2001 to apply his research commercially to the data analysis problems in the drug discovery industry.


Graham Snudden has a degree in Mechanical Engineering but has built his career in software development. He has a particular expertise in data analysis and visualisation, having been involved in the development of commercial solutions for both the engineering and law enforcement communities. While working on systems to infer and visualise organised criminal networks from transactional telephone and financial data, Graham became interested in the application of similar approaches in the life sciences. Since co-founding BlueGnome, he has worked closely with users of microarray technology to develop pragmatic solutions to some of the key challenges faced by the research community.

spacer
Dr Nick Haan trained
spacer
spacer
spacer
Graham Snudden
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

4th Annual Patient Recruitment and Retention in Clinical Trials

13-15 October 2008, Amsterdam

Patient recruitment is now consuming thirty percent of clinical trial time - more time than any other clinical trial activity - and almost half of all trial delays result from patient recruitment problems. As the recruiting culture becomes more sophisticated and the forces affecting patient enrollment grow more numerous and complex, pharmaceutical companies are striving to discover new strategies to facilitate enrollment in clinical trials. With increasing industry pressure to develop, test and market greater numbers of new drugs faster, pharmaceutical companies need to perform clinical trials as quickly as possible. Inefficient patient recruitment processes is a formidable barrier to pharmaceutical companies' success in launching new products. Improving the patient recruitment process is imperative to avoid wasted investments and eliminate costly delays in bringing new drugs to market -- today and even more so in the not-so-distant future. Improved patient recruitment presents one of the largest opportunities for pharmaceutical companies to eliminate delays in clinical trials, thereby making it possible to reduce time to market.  With patent time limits and large overheads meaning that any delays in the development timeline can be disastrous, a good understanding of how to successfully recruit patients for trials is vital for any company looking to succeed.
More info >>

 
News and Press Releases

MipTec, October 14 – 16, 2008, Switzerland

MipTec about to take off by joining forces between Life Sciences Week, ALL-SystemsX.ch-Day, & Jobvector.com    
More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement